NCT05235906 2023-08-09
A Phase II Clinical Study of Surufatinib Combined With Sintilimab in the Treatment of Advanced Gastric Cancer
Sun Yat-sen University
Phase 2 Unknown
Sun Yat-sen University
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Shanghai University of Traditional Chinese Medicine
Assiut University
National Cancer Center, Korea
ChineseAMS
Yonsei University
Chinese PLA General Hospital